Edwards Lifesciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1996
Revenue	6,005	5,382	5,233	4,386	4,348	Upgrade
Revenue Growth (YoY)	11.56%	2.86%	19.29%	0.88%	16.79%	Upgrade
Cost of Revenue	1,380	1,080	1,249	1,081	1,114	Upgrade
Gross Profit	4,625	4,302	3,984	3,306	3,234	Upgrade
Selling, General & Admin	1,825	1,568	1,494	1,228	1,242	Upgrade
Research & Development	1,072	945.2	903.1	760.7	752.7	Upgrade
Other Operating Expenses	220.7	76.5	20.6	405.4	91.9	Upgrade
Operating Expenses	3,117	2,589	2,417	2,395	2,087	Upgrade
Operating Income	1,508	1,713	1,566	911.2	1,147	Upgrade
Interest Expense / Income	17.6	19.2	18.4	15.8	20.7	Upgrade
Other Expense / Income	-110.8	-73.9	-154.2	-21.3	-40.4	Upgrade
Pretax Income	1,601	1,767	1,702	916.7	1,167	Upgrade
Income Tax	198.7	245.5	198.9	93.3	119.6	Upgrade
Net Income	1,402	1,522	1,503	823.4	1,047	Upgrade
Net Income Growth	-7.85%	1.25%	82.55%	-21.35%	44.96%	Upgrade
Shares Outstanding (Basic)	607	619	623	623	625	Upgrade
Shares Outstanding (Diluted)	609	624	631	632	637	Upgrade
Shares Change	-2.37%	-1.11%	-0.11%	-0.75%	-0.66%	Upgrade
EPS (Basic)	2.31	2.46	2.41	1.32	1.68	Upgrade
EPS (Diluted)	2.30	2.44	2.38	1.30	1.64	Upgrade
EPS Growth	-5.74%	2.52%	83.08%	-20.73%	45.13%	Upgrade
Free Cash Flow	642.8	973.6	1,406	647.3	928.5	Upgrade
Free Cash Flow Per Share	1.06	1.57	2.26	1.04	1.49	Upgrade
Gross Margin	77.02%	79.93%	76.13%	75.36%	74.37%	Upgrade
Operating Margin	25.11%	31.82%	29.93%	20.77%	26.38%	Upgrade
Profit Margin	23.35%	28.28%	28.73%	18.77%	24.08%	Upgrade
Free Cash Flow Margin	10.70%	18.09%	26.88%	14.76%	21.35%	Upgrade
Effective Tax Rate	12.41%	13.89%	11.69%	10.18%	10.25%	Upgrade
EBITDA	1,792	1,953	1,884	1,068	1,302	Upgrade
EBITDA Margin	29.84%	36.29%	36.00%	24.35%	29.94%	Upgrade
Depreciation & Amortization	173.1	166.8	163.3	135.4	114.6	Upgrade
EBIT	1,619	1,787	1,720	932.5	1,187	Upgrade
EBIT Margin	26.96%	33.19%	32.88%	21.26%	27.30%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).